Wird geladen...
Effect of Tyrosin Kinase Inhibitors on NK Cell and ILC3 Development and Function
Tyrosin kinase inhibitors (TKI) sharply improved the prognosis of Chronic Myeloid Leukemia (CML) and of Philadelphia(+) Acute Lymphoblastic Leukemia (Ph(+)ALL) patients. However, TKI are not curative because of the development of resistance and lack of complete molecular remission in the majority of...
Gespeichert in:
| Veröffentlicht in: | Front Immunol |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Frontiers Media S.A.
2018
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6207002/ https://ncbi.nlm.nih.gov/pubmed/30405627 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2018.02433 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|